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and Synaptic Transmission
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Manchester, United Kingdom
p38 is a mitogen-activated protein kinase (MAPK), that responds primarily to stress
stimuli. p38 has a number of targets for phosphorylation, including MAPK-activated
protein kinase 2 (MK2). MK2 primarily functions as a master regulator of RNA-binding
proteins, indirectly controlling gene expression at the level of translation. The role
of MK2 in regulating the synthesis of pro-inflammatory cytokines downstream of
inflammation and cellular stress is well-described. A significant amount of evidence,
however, now points to a role for the p38MAPK-MK2 signaling axis in mediating synaptic
plasticity through control of AMPA receptor trafficking and the morphology of dendritic
spines. These processes are mediated through control of cytoskeletal dynamics via
the activation of cofilin-1 and possibly control of the expression of Arc/Arg3.1. There
is evidence that MK2 is necessary for group I metabotropic glutamate receptors long-
term depression (mGluR-LTD). Disruption of this signaling may play an important role
in mediating cognitive dysfunction in neurological disorders such as fragile X syndrome
and Alzheimer’s disease. To date, the role of neuronal MK2 mediating synaptic plasticity
in response to inflammatory stimuli has not yet been investigated. In immune cells,
it is clear that MK2 is phosphorylated following activation of a broad range of cell
surface receptors for cytokines and other inflammatory mediators. We propose that
neuronal MK2 may be an important player in the link between inflammatory states and
dysregulation of synaptic plasticity underlying cognitive functions. Finally, we discuss the
potential of the p38MAPK-MK2 signaling axis as target for therapeutic intervention in a
number of neurological disorders.
Keywords: MK2, p38MAPK, synaptic plasticity, mGluR-LTD, neuroinflammation, cognition, hippocampus, AMPAR
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INTRODUCTION
Over recent years, the importance of bidirectional cross-talk between the immune system
and central nervous system has become increasingly clear. Immune responses are subject to
neuroendocrine modulation (Taub, 2008), while inflammatory signals mediate the activity of neural
networks (Schneider et al., 1998; Pickering et al., 2005; Clarkson et al., 2017). Molecules that
were previously defined by their contribution to the functioning of the immune system, such
as tumor necrosis factor α (TNFα), have been shown also to play important roles in regulating
neuronal activity (Shatz, 2009). Conversely, a role in immune function has emerged for molecules,
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such as γ-Aminobutyric acid (GABA), defined by their role
in neurotransmission (Kerage et al., 2019). The importance
of an inflammatory contribution to neurological disorders has
become increasingly clear and mechanisms through which
inflammatory signaling is transduced into neuronal responses are
of particular interest. The p38 mitogen-activated protein kinase
(MAPK, p38MAPK), phosphorylates MAPK-activated protein
kinase 2 (MK2). The role of this p38MAPK-MK2 signaling
axis in cellular responses to stress and inflammatory signals,
including control of the synthesis and release of inflammatory
signaling molecules, has been delineated in detail, largely
from immune cells (Gaestel, 2006; Menon and Gaestel, 2018).
In neurons, however, the p38MAPK-MK2 signaling axis is
responsible for mediating neurotransmission in response to
activation of perisynaptic group I metabotropic glutamate
receptors (mGluR1/5) on dendritic spines. Expressed in neurons
throughout the brain, activated in response to inflammatory
cues and with a demonstrated role in mediating synaptic
plasticity, the p38MAPK-MK2 signaling axis is an attractive
candidate for mediating crosstalk between inflammatory and
neuronal signaling. Here, we will discuss what is known about
activation of the p38MAPK-MK2 axis in response to inflammatory
stimuli, the role it plays in mediating synaptic plasticity, discuss
the potential of this signaling pathway for mediating cross-
talk between inflammatory signals and neurotransmission and
discuss settings within which targeting this signaling system may
prove efficacious.
THE p38MAPK-MK2 SIGNALING AXIS
MAPK-signaling cascades are highly conserved intracellular
signaling pathways that convert external stimuli, usually through
cell-surface receptors, into a range of cellular responses (Seger
and Krebs, 1995). These signaling pathways are ubiquitous
across the eukaryotic domain (Avruch, 2007) and mediate
a great diversity of cellular processes, such as proliferation,
differentiation, or apoptosis (Qi and Elion, 2005; Keshet and
Seger, 2010; Morrison, 2012). These processes largely control
the expression of a network of regulatory genes (Whitmarsh,
2007). Each cascade of conventional MAPKs is composed of a
set of three sequentially acting kinases: an MAPK, an MAPK
kinase (MAP2K), and an MAP2K kinase (MAP3K) (Cargnello
and Roux, 2011). The MAP3Ks, at the top of the cascade,
are protein serine/threonine kinases, often activated through
phosphorylation and/or as a result of their interaction with a
small GTP-binding protein of the Ras/Rho family in response to
extracellular stimuli (Chiariello et al., 2010). MAP3K activation
leads to the phosphorylation and activation of a MAP2K,
which then activates a MAPK through dual phosphorylation on
threonine and tyrosine residues within a conserved threonine-X-
tyrosine motif (Cargnello and Roux, 2011).
p38MAPK is a MAPK, that in mammalian cells is expressed
in four splice variants: p38α, p38β, p38γ, and p38δ, with
differential phosphorylation of molecular targets (Cuadrado and
Nebreda, 2010). P38MAPK is activated by the MAP2Ks, MKK3,
and MKK6 (Zarubin and Han, 2005), via dual phosphorylation
on threonine-180 and tyrosine-182 (Raingeaud et al., 1995).
The principal role of p38MAPK is in co-ordinating molecular
responses within the cell to stimuli associated with diverse
stressors (Coulthard et al., 2009). Stressors can involve changes in
the immediate extracellular microenvironment, such as osmotic
(Westfall et al., 2004) or thermal (Li et al., 2018) stress,
or the detection of pathogens (Cargnello and Roux, 2011).
Alternatively, pathology at the level of organ or organism
can be detected through intercellular signaling molecules, such
as chemoattractants, cytokines, and chemokines (Menon and
Gaestel, 2018). These signals are transduced into a p38MAPK-
mediated cellular response through receptors, generally at the
cell surface and the subsequent initiation of MAPK signaling
cascades, as described above. Through phosphorylation and
activation of a range of targets, p38MAPK co-ordinates a cellular
response to these inputs, which can include the amplification
of inflammatory responses though synthesis and release of
pro-inflammatory cytokines (Ronkina et al., 2010; Menon and
Gaestel, 2018) and altering the morphology or motility of the cell
through changes in the actin cytoskeleton (Scharf et al., 2013).
Many of these processes are co-ordinated by MK2.
MK2 is activated by the α and β isoforms of p38MAPK, through
phosphorylation at Thr-222, Ser-272 and Thr-334 (Freshney
et al., 1994; Han et al., 1994; Rouse et al., 1994; Li et al.,
2018). MK2 has multiple targets for phosphorylation, but its
primary function is as a master regulator of RNA binding
proteins (Culbert et al., 2006; Gaestel, 2006; Gais et al., 2010;
Gurgis et al., 2014; Soni et al., 2019). Experimental evidence
indicates that MK2 regulates the stability of genes that harbor
adenine/uridine-rich elements (AREs) in their 3’-untranslated
region (3’-UTRs). The control of mRNA stability and translation
by MK2 is dependent on AU-rich elements in the 3’ untranslated
mRNA region, and on RNA-binding proteins. Deletion of MK2
leads to an impaired inflammatory response, which is mainly due
to reduced TNF-mRNA stability or translation (Gaestel, 2006).
ACTIVATION OF p38MAPK-MK2
SIGNALING AXIS IN RESPONSE TO
INFLAMMATION
The p38MAPK-MK2 signaling axis is embedded in a signaling
cycle both downstream of receptors for inflammatory stimuli
and upstream of the synthesis and release of pro-inflammatory
signaling molecules, allowing it to function as an amplifier
of inflammation (Menon and Gaestel, 2018). A broad variety
of receptors for inflammatory stimuli and signaling molecules
converging through shared pathways, unite at this signaling
axis to produce a cellular response (Figure 1). The immune
system uses pattern recognition receptors (PRRs) (Takeuchi and
Akira, 2010; Amarante-Mendes et al., 2018) for the detection
of molecules associated with pathogens (pathogen-associated
molecular patterns (PAMPs) and damage (damage-associated
molecular patters (DAMPs) (Tang et al., 2012). The receptor
for advanced glycation end-products (RAGE) is a multi-ligand,
cell-surface PRR, which initiates cellular responses to DAMPs.
It binds advanced glycation end-products (AGEs)- proteins or
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FIGURE 1 | p38MAPK-MK2 axis is activated in response to diverse inflammatory stimuli. p38MAPK is a point of convergence for a wide diversity of intracellular
signaling pathways triggered by pattern recognition receptors and receptors for cytokines and other inflammatory signaling molecules. Following activation of RAGE,
(A) the p38MAPK-MK2 signaling axis is activated downstream of p21Ras, via MKK3/6 (Yeh et al., 2001; Ott et al., 2014). Activation of receptors in the IL1R
superfamily (B), including the toll-like receptors, signal through MyD88 and IRAK, to phosphorylate TRAF6, which in turn activates MKK3/6 and then p38MAPK
(Martin and Wesche, 2002; Dunne and O’Neill, 2003). (C) Activation of TGFβR, meanwhile leads to activation of p38MAPK, via TAK1 phosphorylation of MKK3/6 (Yu
et al., 2002). This TAK1-dependent pathway is also activated downstream of TNFR1 and TLR3 activation, via RIP1 (Shin et al., 2009). (D) Activation of TNF receptor
1 activates p38MAPK via TRAF2 phosphorylation of MKK3/6.
lipids, which have become glycated after exposure to sugars—
which accumulate in the extracellular space with increasing age,
inflammation, oxidative stress, or as a consequence of ischemia-
reperfusion or high glucose (Singh et al., 2001). As well as binding
AGEs, RAGE is also activated by calgranulins (Hofmann et al.,
1999), amyloid-beta (Aβ) peptides (Yan et al., 1996; Takuma
et al., 2009; Piras et al., 2016), associated with Alzheimer’s disease,
and high-mobility group protein 1 (HMGB1) (Huebener et al.,
2015), a chromatin protein which functions in the nucleus, but
is released by immune cells as a leaderless cytokine (Klune
et al., 2008). Activation of RAGE initiates, via p21Ras protein
activator 1 (Figure 1A), a MAPK signaling cascade culminating
in phosphorylation of MK2 by p38MAPK (Ott et al., 2014). In
immune cells, the p38MAPK-MK2 signaling axis is necessary for
the synthesis and release of inflammatory cytokines in response
to RAGE activation (Yeh et al., 2001).
Toll-like receptors (TLRs) are a family of archetypal PRRs,
which detect molecular patterns associated with pathogens
(Akira et al., 2001; Janeway and Medzhitov, 2002; Figure 1B).
Lipopolysaccharide (LPS), the material from which the cell
wall of gram positive bacteria is constructed, is a ligand for
toll-like receptor 4 (TLR4) (Park and Lee, 2013), and can
be used experimentally to induce an inflammatory response.
Indeed, p38MAPK was first discovered through its activation,
via tyrosine phosphorylation, in response to LPS-induced
TLR4 activation (Han et al., 1993, 1994). Toll-like receptor
3 (TLR3) meanwhile, is expressed in the cytoplasm or
in the membrane of endosomes (Chaturvedi and Pierce,
2009) where it detects strings of nucleotides indicative of
a viral infection (Perales-Linares and Navas-Martin, 2013)
(Figure 1B). Polyriboiosinic:polyribocytidylic acid [poly(I:C)]
is a synthetic analog of double-stranded RNA, which can
be used experimentally as an immunostimulant to induce an
inflammatory response via activation of TLR3 (Farkas et al.,
2019). Using Poly(I:C) to stimulate cells, it was demonstrated
that the cellular response to activation of TLR3 is dependent on
the p38MAPK-MK2 signaling axis, through a pathway involving
myeloid differentiation primary response 88 (myD88) and
TIR-domain-containing adaptor-inducing interferon-β (TRIF)
(Johnsen et al., 2012; Figure 1B). MK2, therefore functions
an effector molecule in cellular responses to detection of both
bacterial or viral pathogens.
The TLRs are part of a larger family of receptors, characterized
by a toll-IL-1-receptor (TIR) domain (Boraschi et al., 2018). This
group includes the interleukin-1 family of receptors, composed
of interleukin receptor-1 (ILR1) [a receptor for the leaderless
pro-inflammatory cytokines interleukin-1α and β (IL-1α and
IL-1β)], interleukin receptor-18 (ILR18), interleukin receptor-
like 1 (IL1RL1), receptors for interleukin-18 and interleukin-33,
respectively (Dinarello, 2018). The IL-1 receptor family signal
through MyD88 and interleukin-1 receptor associated kinase
(IRAK) (Martin and Wesche, 2002). IRAK activates the classic
MAPK-signaling pathway via tumor necrosis factor receptor
associated factor 6 (TRAF6), leading, via MKK3 and MKK6
to activation of the p38MAPK-MK2 signaling axis (Dunne and
O’Neill, 2003; Figure 1B). Evidence for MK2 phosphorylation
following activation of receptors in the IL-1R family includes in
responses to IL-1β (Raingeaud et al., 1995; Dunne and O’Neill,
2003), IL-33 (Helbig et al., 2020; Petrova et al., 2020), and IL-18
(Dunne and O’Neill, 2003).
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Transforming growth factor-β (TGF-β) is a multifunctional
cytokine, released in latent form and activated by proteolysis
by matrix metalloproteinases on the cell surface (Karsdal
et al., 2002). Upon activation, TGFβ functions as a ligand for
dimeric, single pass serine/threonine receptors made up of the
subunits TGFβ receptor 1 (TGFβR1/ALK5) and TGFβ receptor
2 (TGFβR2). Binding of TGFβ to TGFβR1 activates a signaling
cascade involving MKK3/6, p38MAPK and MK2, through the
phosphorylation of phosphorylation of TGFβ-activated kinase 1
(TAK1) (Figure 1C; Yu et al., 2002).
Tumor necrosis factor-α (TNFα) (Menon and Gaestel, 2018) is
a pro-inflammatory cytokine released into the extracellular space,
largely by leukocytes during the acute stage of inflammation
(Parameswaran and Patial, 2010; Wajant and Siegmund, 2019),
and functions as the ligand for two cell surface receptors: tumor
necrosis factor receptor 1 and 2 (TNFR1 and TNFR2) (Idriss and
Naismith, 2000). TNFR1 activates MAPK-signaling cascades via
TNFR1-associated death domain (TRADD) and TNF receptor-
associated factor 2 (TRAF2). TRAF2 phosphorylates MKK3/6
(Shi and Sun, 2018; Figure 1D). A separate pathway leading
to phosphorylation of MKK3/6 is via receptor-interacting
protein-1 (RIP1) phosphorylation of TAK1 (Shin et al., 2009)
TAK1 phosphorylation is a point of confluence not only
with signaling cascades downstream of TGFβR1 (described
above), but also via RIP1 activated by TLR3 on endosomes
(Kawasaki and Kawai, 2014).
The full range of inflammatory pathways, which lead to
activation of the p38MAPK-MK2 axis is broader than can be
described within the scope of this review. Other receptors
for inflammatory stimuli which have been demonstrated to
activate the p38MAPK-MK2 signaling axis include (but are not
limited to): monocyte chemoattractant protein 1/chemotactic
cytokine ligand 2 (MCP-1/CCL2) activation of chemotactic
cytokine receptor 2 (CCR2) (Cho and Gruol, 2008), and
interferon-γ activation of interferon-γ receptor (IFNGR)
(Culbert et al., 2006).
p38MAPK-MK2 SIGNALING AXIS IN
NEURONS
All p38MAPK isoforms are expressed in the mouse brain, with the
p38α and β isoforms particularly prominent in the cerebral cortex
and hippocampus, with p38α most abundant in neurons (Lee
et al., 2000; Beardmore et al., 2005). MK2 is also constitutively
expressed in neurons, where it is activated by p38α and β and
plays an important role in mediating synaptic plasticity induced
by group I metabotropic glutamate receptors (mGluR1/5) (Kemp
and Bashir, 1997; Palmer et al., 1997; Moult et al., 2008;
Gladding et al., 2009; Sanderson et al., 2016; Privitera et al.,
2019; Figure 2A). In the hippocampus, activation of perisynaptic
mGluR5 on excitatory neurons (Lujan et al., 1996) mediates a
prolonged activity-dependent reduction in the synapse efficacy
(long-term depression: mGluR-LTD) (Gladding et al., 2009).
The mechanisms underlying mGluR-LTD have been extensively
studied at hippocampal Schaffer collateral-CA1 synapses, where
it can be induced through the application of paired-pulse
low frequency stimulation (Kemp and Bashir, 1997) or with
the mGluR5 agonist (S)-3,5-dihydroxyphenylglycine (DHPG)
(Palmer et al., 1997).
The p38MAPK-MK2 signaling axis (Thomas et al., 2008; Eales
et al., 2014), activated downstream of mGluR5, controls the
molecular machinery in dendritic spines necessary for induction
of mGluR-LTD. This includes the molecular regulators of actin
remodeling and trafficking of the α-Amino-3-hydroxy-5-methyl-
4-isoxazoleproprionic acid receptor (AMPA-R) subunits, GluA1
and GluA2 (Corrêa and Eales, 2012; Eales et al., 2014; Wall
et al., 2018; Privitera et al., 2019). The molecular mechanisms
underlying synaptic plasticity often vary in different brain regions
(Gladding et al., 2009). At CA1 dendrites, mGluR-LTD is
mediated by Ca2+-independent mechanisms dependent on a
cascade triggered by mGluR5 activation leading to the sequential
activation of repressor activator protein 1 (Rap1), MKK3/6,
p38MAPK and MK2 (Huang et al., 2004).
The morphology of dendritic spines, and GluA1/GluA2
trafficking is controlled through proteins which act to reorganize
dynamic elements of the cytoskeleton. A principal target of
MK2, in this regard, is LIM domain kinase 1 (LIMK1), which is
phosphorylated at Ser-323 (Kobayashi et al., 2006) and regulates
the activity of proteins involved in cytoskeletal remodeling.
Cofilin1 is a target of LIMK1 (Meng et al., 2002) and, when
activated coordinates the depolymerization of actin filaments (F-
actin) into actin monomers (G-actin). The dynamic ratio between
F-actin and G-actin is largely responsible for the structural
changes of the dendritic spine. A switch toward G-actin,
triggered through the p38MAPK-MK2-LIMK-cofilin1 signaling
cascade drives the spine toward decreased size and away from a
mushroom-like morphology (Honkura et al., 2008; Figure 2A).
These structural changes are associated with LTD and decreased
neurotransmission through the synapse.
AMPA-R trafficking mediating mGluR-LTD is largely
coordinated by the expression of the activity-dependent
immediate early gene, Arc/Arg3.1 (Snyder et al., 2001; Bramham
et al., 2008; Park et al., 2008; Waung et al., 2008; Smith-Hicks
et al., 2010; Wall et al., 2018). Transcripts of Arc/Arg3.1 are
rapidly transported to dendrites, enabling locally controlled
translation at post-synaptic ribosomes (Bramham et al., 2008).
Protein expression of Arc/Arg3.1 is regulated at individual
dendritic spines through control of translational (Waung et al.,
2008); polyubiquitination and targeting for proteolysis (Mabb
and Ehlers, 2010; Mabb et al., 2014; Mabb and Ehlers, 2018; Wall
et al., 2018). Translation and expression of Arc/Arg3.1 facilitates
AMPA-R endocytosis via interaction with cytoskeletal elements
(Chowdhury et al., 2006; Waung et al., 2008; DaSilva et al., 2016;
Wall and Corrêa, 2018). Although the mechanism by which
the MK2 cascade may control Arc/Arg3.1 expression is unclear,
the Arc/Arg3.1 gene contains the serum response element
(SRE), which may be directly phosphorylated by serum response
factors (SRF) (Ronkina et al., 2011), under the control of MK2.
Additionally, as a master regulator of RNA-binding proteins
(Soni et al., 2019), MK2 may also control the phosphorylation
state of proteins involved in regulating local translation and may
regulate Arc/Arg3.1 expression both at the transcriptional and
local translational level.
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FIGURE 2 | (A) p38MAPK-MK2 axis is necessary for mGluR-LTD at Schaffer collateral—CA1 synapses. Activation of perisynaptic group I mGluR induced long-term
depression is dependent on activation of the p38MAPK-MK2 axis. The p38MAPK-MK2-LIMK1-cofilin signaling cascade leads to depolymerization of the actin
cytoskeleton, with a decrease in ratio of filamentous (F-) to globular (G-) actin (Meng et al., 2002; Kobayashi et al., 2006; Honkura et al., 2008). (B) Putative
mechanism through which p38MAPK-MK2 signaling axis mediates neurotransmission in response to inflammatory stimuli. Pattern recognition receptors, receptors for
cytokines, and receptors for other inflammatory signaling molecules trigger intracellular signaling cascades, which converge at the p38MAPK-MK2 signaling axis (see
section “Activation of p38MAPK-MK2 Signaling Axis in Response to Inflammation” and Figure 1 for more detail). MK2 controls cytoskeletal dynamics and receptor
trafficking, as described in section “p38MAPK-MK2 Signaling Axis in Neurons” and A). Through this mechanism, we propose that the p38MAPK-MK2 signaling axis
controls synapse strength in response to diverse inflammatory stimuli.
The molecular events controlled by the p38MAPK-MK2
signaling axis mediate changes in synaptic strength that impact at
cognitive and behavioral levels. Intact mGluR-LTD is necessary
for maintaining cognitive flexibility (Eales et al., 2014), memory
extinction (Lüscher and Huber, 2010), and setting the ground for
functional long-term potentiation (LTP) at the synapse (Walsh
et al., 2002), underlying the formation of new memories. The
Barnes maze task, an assay for spatial learning, can be used to
measure levels of cognitive flexibility, by adjusting the position of
the exit hole after a period of training. While the initial spatial
learning task was intact in MK2 knockout mice, they showed
severe impairments in relearning the task, demonstrating a deficit
in reversal learning (Privitera et al., 2019). These deficits resonate
with impairments seen in Fragile-X syndrome (Bear et al., 2004)
and Alzheimer’s disease (Shankar et al., 2008), which involve
dysfunction of mGluR-LTD.
p38MAPK-MK2 SIGNALING AXIS AT
CONFLUENCE OF INFLAMMATORY AND
SYNAPTIC SIGNALING
Under inflammatory conditions, adaptive structural plasticity
of dendritic spines is impaired (Zou et al., 2016) and
AMPA-R internalization is increased (Park and Lee, 2013),
though the mechanisms underlying these changes are not fully
characterized. The p38MAPK-MK2 signaling axis, embedded both
in pathways downstream of receptors for a broad range of
inflammatory mediators and a necessary effector of mGluR-
LTD, is a prime candidate for mediating inflammation-induced
changes in neurotransmission. Activated downstream of stress
and inflammatory signals in other contexts, we propose that
MK2, expressed in neurons, may be an important player
in the dysregulation of cognitive and effective functions
following injury, infection or as a consequence of autoimmune
reactions (Figure 2B).
Central to this hypothesis is the neuronal expression of
receptors for cytokines and/or chemokines, PRRs and other
receptors that respond to inflammatory stimuli. Indeed, many
of the receptors that activate the p38MAPK-MK2 signaling
axis in immune cells are also expressed in neurons, either
constitutively, or induced under inflammatory conditions.
Neurons constitutively express TNFR1 (Probert, 2015), while
TNFR2 is largely restricted immune and glial cells. Neuronal
TNFR1 can also be upregulated in response to insult (Pradillo
et al., 2005), mediating processes involved in preconditioning. IL-
1R, meanwhile, is expressed in neurons and, more specifically, in
dendritic spines where it has been shown to influence synaptic
plasticity (Prieto et al., 2015). Amongst other receptors in the IL-
1R superfamily, the interleukin-18 receptor (IL-18R) is expressed
in neurons, where it is involved in mediating neuronal responses
to IL-18 (Alboni et al., 2010). Evidence for neuronal expression
of interleukin-1 receptor like receptor (IL1RLR), also known
as growth stimulation expressed gene 2 (ST2) is more limited.
With expression in sensory neurons well characterized (Liu et al.,
2016), but limited data supporting expression of this receptor in
central neurons (Fairlie-Clarke et al., 2018).
Amongst the PRRs, there is strong evidence for both
constitutive expression of TLR4 in neurons (Leow-Dyke et al.,
2012), and upregulation of expression with aging and in pro-
inflammatory conditions, such as high levels of extracellular Aβ
(Calvo-Rodríguez et al., 2017). There is also strong evidence for
endosomal TLR3 expression in neurons, where the receptor not
only contributes to mediating cellular responses to pathogens,
but also plays a role in regulation of neuronal morphology
(Hung et al., 2018). Neuronal expression of RAGE is also
well documented (Sasaki et al., 2001), with this receptor
heavily implicated in the pathogenesis of neurodegenerative
disorders, particularly Alzheimer’s disease (Cai et al., 2016),
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and in contributing to neurological sequelae associated with
diabetes (Toth et al., 2007) and other systemic pathologies with
an inflammatory element (Gasparotto et al., 2019). Receptors
for TGF-β are also expressed in neurons, where they have
been implicated in mediating cell fate in response to insult
(König et al., 2005).
As described in section “Activation of p38MAPK-MK2
Signaling Axis in Response to Inflammation” above, these
cytokine receptors and PRRs activate MAPK-signaling cascaded
culminating in the p38MAPK-MK2 axis. As described in section
“p38MAPK-MK2 Signaling Axis in Neurons,” phosphorylated
MK2 regulates synaptic plasticity through transcriptional, post-
transcriptional and post-translational control of a suite of
effector proteins, which lead to changes in the morphology of
dendritic spines and endocytosis of AMPA receptors. While this
has been demonstrated in response to activation of group I
metabotropic glutamate receptors (mGluR-LTD) (Eales et al.,
2014), we suggest that the importance of MK2 in effector
pathways downstream of cytokine receptors and PRRs make this




A key role for the p38MAPK-MK2 signaling axis has been
identified as an effector of cellular responses to inflammatory
signals and stimuli. The same signaling axis has also been
shown to be a key link in the processes mediating mGluR-
LTD. Neuroinflammation is a ubiquitous or near ubiquitous
feature of neurological disorders and we identify the p38MAPK-
MK2 signaling axis as a potentially important mechanistic
link between neuroinflammation and synaptic dysregulation
underlying cognitive impairments in neurological disorders, such
as Alzheimer’s disease. MK2-mediated mGluR-LTD is necessary
for maintaining cognitive flexibility, the loss of which is an
early clinical sign of Alzheimer’s disease. Inhibitors of p38MAPK
have been trialed in a number of contexts where inflammation
makes an important contribution to disease etiology (Lee and
Kim, 2017). These inhibitors, however, have suffered from poor
efficacy and a high burden of adverse effects (Hammaker and
Firestein, 2010). Inhibitors which specifically target p38MAPK
mediated activation of MK2 or target the activity of MK2
itself may offer more promise, with a narrower focus. The
p38MAPK-MK2 signaling axis is a promising target for therapeutic
intervention, where inflammation contributes to dysregulation of
neuronal network activity. More evidence, however, is necessary
to clarifying the contribution of this signaling axis.
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